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Abstract Heterogeneous photocatalysis using the semi-
conductor titanium dioxide (TiO2) has proven to be a
promising treatment technology for water purification. The
effectiveness of this oxidation technology for the destruc-
tion of pharmaceuticals has also been demonstrated in
numerous studies. This review highlights recent research
on TiO2 photocatalytic treatment applied to the removal of
selected pharmaceuticals. The discussions are tailored
based on the therapeutic drug classes as the kinetics and
mechanistic aspects are compound dependent. These clas-
ses of pharmaceuticals were chosen because of their
environmental prevalence and potential adverse effects.
Optimal operational conditions and degradation pathways
vary with different pharmaceutical compounds. The main
conclusion is that the use of TiO2 photocatalysis can be
considered a state-of-the-art pharmaceutical wastewater
treatment methodology. Further studies are, however,
required to optimize the operating conditions for maximum
degradation of multiple pharmaceuticals in wastewater
under realistic conditions and on an industrial scale.
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Introduction
Poor sanitation, water scarcity, deterioration of water qual-
ity, emergence of waterborne diseases, and lack of clean
water supply are all posing global challenges due to the
rising demand by an increasing world population. Further
demands on water resources have resulted from the intro-
duction of emerging recalcitrant contaminants or xenobiot-
ics, such as pharmaceuticals, endocrine disruptors,
surfactants, and personal care products, which are complex
and resistant to degradation. The number of studies high-
lighting the prevalence of pharmaceuticals in water envi-
ronments has increased significantly since 2000, Heberer
(2002), Tixier et al. (2003), Fent et al. (2006), and Miège
et al. (2009). This has raised widespread concern about the
lack of knowledge of potential effects of pharmaceutical
compounds and their metabolites on human and aquatic
organisms, despite occurring in trace quantities ranging from
ng/L to lg/L, Kümmerer (2009) and Mompelat et al. (2009).
Existing sewage treatment technology is considered
inadequate for the removal of emerging micropollutants, as
they are not designed to handle this specific class of pol-
lutants, Suárez et al. (2008). The failure of conventional
wastewater treatment plants (WWTPs) to remove phar-
maceuticals clearly shows the urgent need for innovative
technologies that can effectively deal with these com-
pounds, Ternes (1998) and Zhang et al. (2008a). Advanced
oxidation processes (AOPs) are regarded as appropriate to
degrade pollutants, which are known to be non-biode-
gradable or have low biodegradability, persistence, and
possess high chemical stability. AOPs for water and
wastewater treatment include photolysis and photocataly-
sis, ozonation, Fenton and photo-Fenton, ultrasound radi-
ation, sonolysis, electrochemical oxidation, and wet air
oxidation.
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